Covered recipient · General Payments record
CAROLYN L WEINSTEIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,668.84
- Reported across 87 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.81 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $132.29 | 2 |
| Astellas Pharma US Inc | $51.31 | 2 |
| Smith & Nephew, Inc. | $50.21 | 2 |
| Organon LLC | $46.19 | 3 |
| MILLICENT US INC | $37.95 | 2 |
| Daiichi Sankyo Inc. | $37.51 | 2 |
| CooperSurgical, Inc. | $35.59 | 2 |
| Exeltis, USA Inc. | $18.69 | 1 |
| SHIELD THERAPEUTICS INC | $16.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.12 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108392557 | CMS |
| ABBVIE INC. | $111.17 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108392559 | CMS |
| Astellas Pharma US Inc | $24.32 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139496240 | CMS |
| Astellas Pharma US Inc | $26.99 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139507159 | CMS |
| CooperSurgical, Inc. | $19.08 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150797449 | CMS |
| CooperSurgical, Inc. | $16.51 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150797535 | CMS |
| Daiichi Sankyo Inc. | $17.98 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089497262 | CMS |
| Daiichi Sankyo Inc. | $19.53 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089497264 | CMS |
| Exeltis, USA Inc. | $18.69 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150021315 | CMS |
| MILLICENT US INC | $18.31 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150917385 | CMS |
| MILLICENT US INC | $19.64 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150917387 | CMS |
| Organon Llc | $14.59 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136275273 | CMS |
| Organon Llc | $16.97 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136275281 | CMS |
| Organon Llc | $14.63 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136275277 | CMS |
| SHIELD THERAPEUTICS INC | $16.07 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150154356 | CMS |
| Smith+Nephew, Inc. | $20.81 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149609425 | CMS |
| Smith+Nephew, Inc. | $29.40 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149609427 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.